Emulsion polymerization was used to prepare methylsilsesquioxane derivatives with an
average particle size of 0.2−5.0 μm and various topological morphologies. Particles with an
average particle size of 0.2−2.0 μm were prepared by emulsion polymerization using close
to the critical micelle concentration of a nonionic emulsifier and a small amount of sodium
hydroxide as a catalyst, whereas particles with an average particle size of 2.0−5.0 μm were
obtained by suspension polymerization using a small amount of sodium hydroxide as a
catalyst. Aggregation between the obtained particle colloids was not observed with the
addition of an anionic emulsifier to the colloid solution at the earliest point in particle growth.
A nonionic or cationic emulsifier was not effective, since the adsorption or diffusion of anionic
emulsifier onto the particle colloids was accelerated due to the plus ζ potential of their
surfaces.
A change in the morphological topology of particles of methylsilsesquioxane derivatives is observed with a change in the silicone monomer formulation. The particles change from a spherical shape to a hollow hemispherical shape with an increase in the content of silicaforming monomers in methylsilsesquioxane-forming monomers, whereas the spherical shape does not change with the addition of dimethyl silicone-forming monomers to methylsilsesquioxane-forming monomers. The intermediate shape is a sphere surrounded by a wrinkly surface, like a soccer ball, and the particle finally becomes a hollow hemisphere. These phenomena were examined by FT-IR, 29 Si CP/MAS NMR (solid-state), and XPS spectra from the perspective of internal steric stress due to tetra-or trifunctional units in the particle core.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.